Pharmacogenomics in Drug Discovery

Pharmacogenomics is the study of genome's function in responding to drugs.It is mixture of the genomics and pharmacology. Pharmacogenomics analyzes  how an individual's genetic makeup influences his / her response to drugs. It deals with the effect of genetic variation acquired and inherited ondrug reaction in patients by attributing gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug intake, delivery, metabolism, and elimination) and pharmacodynamic. For certain cases the term pharmacogenomics is used interchangeably with pharmacogenetics.

 

  • Pharmacometrics
  • Target based Drug Discovery
  • Reserve Pharmacology
  • Pharmacokinetic aspects

Related Conference of Pharmacogenomics in Drug Discovery

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Pharmacogenomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in